1 |
LCK
| [10] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | D03658
D03658
|
Dasatinib
| [2] 51 51, 85 |
2 |
LCK
| [10] NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency | D06414
D06414
|
Dasatinib
| [2] 51 51, 85 |
3 |
LEPR
| [6] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, JAK-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease | D05014
D05014
|
Metreleptin
| [1] 265 265 |
4 |
LIPA
| [3] Steroid biosynthesis Steroid biosynthesis, Lysosome, Cholesterol metabolism | D10377
D10377
|
Sebelipase alfa
| [1] 19 19 |
5 |
LTA
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection | D00742
D00742
|
Etanercept
| [17] 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 |
6 |
LTA
| [7] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection | D10187
D10187
|
Pateclizumab
| [1] 46 46 |
7 |
LTB
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis | D08866
D08866
|
Baminercept
| [4] 13 13, 46, 53, 97 |
8 |
LINGO1
| - | D11767
D11767
|
Opicinumab
| [1] 13 13 |